Neuroendocrine Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
SKU : PH362
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Neuroendocrine Cancer Market ?
Neuroendocrine Cancer Market is expected to grow at a CAGR of 10.6% during the forecast period (2024-2031)
Who are the key players in Neuroendocrine Cancer Market ?
Major players are Novartis AG, Pfizer Inc., Ipsen, Tarveda Therapeutics, Progenics Pharmaceuticals, Inc., Hutchison Medipharma Limited, Dauntless Pharmaceuticals Inc., Exelixis, Inc., Advanced Accelerator Applications and Argos Therapeutics Inc.
Related Reports
pharmaceuticalsNeuroendocrine Tumor Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
Starting from
$4350
pharmaceuticalsAlternative Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
Starting from
$4350
pharmaceuticalsPenile Cancer Treatment Market Size, Share, Forecast and Outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350